GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EV Biologics Inc (OTCPK:YECO) » Definitions » Shares Buyback Ratio %

EV Biologics (EV Biologics) Shares Buyback Ratio % : 0.00 (As of May. 21, 2024)


View and export this data going back to 2015. Start your Free Trial

What is EV Biologics Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. EV Biologics's current shares buyback ratio was 0.00%.


EV Biologics Shares Buyback Ratio % Historical Data

The historical data trend for EV Biologics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EV Biologics Shares Buyback Ratio % Chart

EV Biologics Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17
Shares Buyback Ratio %
- - 32.60 -49.97 -0.48

EV Biologics Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Jun17 Dec17
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.48 - - -

EV Biologics Shares Buyback Ratio % Calculation

EV Biologics's Shares Buyback Ratio for the fiscal year that ended in Jun. 2017 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2016 ) - Shares Outstanding (EOP) (A: Jun. 2017 )) / Shares Outstanding (EOP) (A: Jun. 2016 )
=(2.39944 - 2.41107) / 2.39944
=-0.48%

EV Biologics's Shares Buyback Ratio for the quarter that ended in Dec. 2017 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2017 ) - Shares Outstanding (EOP) (A: Dec. 2017 )) / Shares Outstanding (EOP) (A: Jun. 2017 )
=(2.41107 - 2.41107) / 2.41107
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EV Biologics Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of EV Biologics's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


EV Biologics (EV Biologics) Business Description

Traded in Other Exchanges
N/A
Address
1621 Central Avenue, Cheyenne, WY, USA, 82001
EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.
Executives
Daniel S Mckinney director, 10 percent owner, officer: CEO TWO IFC, 19TH FLOOR, 8 FINANCE STREET, CENTRAL, HONG KONG F4 000000
Michael W Harlan director C/O WASTE CONNECTIONS, INC., 610 APPLEWOOD CRESCENT, SUITE 200, VAUGHAN A6 L4K 0C3

EV Biologics (EV Biologics) Headlines

From GuruFocus

EV Biologics Signs MSA with LONZA Cell & Gene Therapy

By ACCESSWIRE ACCESSWIRE 05-17-2022

EV Biologics NFT Dividend Information

By ACCESSWIRE ACCESSWIRE 08-09-2021

EV Biologics Updates on FINRA Filings

By ACCESSWIRE ACCESSWIRE 03-09-2022

EV Biologics Signs LOI with Lonza Cell & Gene Therapy

By ACCESSWIRE ACCESSWIRE 07-22-2021

EV Biologics Updates on Funding and Sales

By ACCESSWIRE 10-02-2023

EV Biologics NFT Dividend Update

By ACCESSWIRE ACCESSWIRE 07-19-2021

EV Biologics Updates on NFT Minting

By ACCESSWIRE ACCESSWIRE 09-28-2021